Author,Title,Journal,ISSN,Publisher,Date,Volume,Number,Page,URL,URL(DOI)
BURNETT AKW,The addition of gemtuzumab ozogamicin to induction chemotherapy for AML improves disease free survival without extra toxicity : preliminary analysis of 1115 patients in the MRC AML15 Trial,Blood,,,2006,108,11,8a,https://cir.nii.ac.jp/crid/1570009750995515904,